Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now

Core Viewpoint - AEON Biopharma, Inc. (AEON) has experienced a bearish trend with a 23.2% loss over the past week, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be increasing [1] Technical Analysis - The hammer chart pattern indicates a possible bottom formation, suggesting that selling pressure may be subsiding [1][3] - A hammer pattern typically forms during a downtrend when the stock opens lower, makes a new low, but then closes near or above the opening price, indicating a shift in control from bears to bulls [2][3] Fundamental Analysis - There has been a notable upward trend in earnings estimate revisions for AEON, with the consensus EPS estimate increasing by 23.4% over the last 30 days, indicating strong agreement among analysts about improved earnings potential [4] - AEON holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which historically outperform the market [4] - The Zacks Rank serves as a timing indicator, suggesting that AEON's prospects are beginning to improve, reinforcing the bullish case for the stock [4]